Flags

Financial distress

Jyong Biotech

NMQ:MENS · KYG831161065

BiotechnologySmall

360° View

no current rank

Value—

Price/Sales—

Price/Earnings—

Price/Book100

Dividend Yield1

Growth36

Revenue Growth—

Profit Growth30

Capital Growth53

TSR 52w1

Safety8

Leverage25

Liquidity27

Refinancing14

Combined—

Sentiment8

Analyst Opinions—

Pro Holdings10

Opinion Changes—

Market Pulse5

Profile

CountryTaiwan

IndustryBiotechnology

SizeSmall

TypePublic Company

ExchangeNASDAQGM

Founded2018

Websitejyongbio.com

ISINKYG831161065

Last UpdateApr 2, 2026

Index & Theme

Pain ManagementOncologyUrologyAlternative Medicine

Description

Jyong Biotech Ltd. is a science-driven biotechnology company. The company is committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an…

Similar Stocks

The companies this stock is ranked against.

Compare Jyong Biotech with its peers

Zai Lab

HKG:9688

CountryChina

IndustryBiotechnology

SizeSmall

Full Stock Analysis →

Wave Life Sciences

NMQ:WVE

CountrySingapore

IndustryPharmaceuticals

SizeSmall

Full Stock Analysis →

Clinuvel Pharmaceuticals

ASX:CUV

CountryAustralia

IndustryBiotechnology

SizeSmall

Full Stock Analysis →

Telix Pharmaceuticals

ASX:TLX

CountryAustralia

IndustryBiotechnology

SizeMedium

Full Stock Analysis →

Mesoblast

ASX:MSB

CountryAustralia

IndustryBiotechnology

SizeSmall

Full Stock Analysis →

KYORIN Holdings

TYO:4569

CountryJapan

IndustryPharmaceuticals

SizeMedium

Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View

1 · Watch OutGood· 100

Value

1 · ExpensiveGood Value· 100

Quality

1 · Weak FundamentalsHigh Quality· 100

Growth

1 · Tough TimesHigh Growth· 100

Safety

1 · High LeverageWell-Financed· 100

Sentiment

1 · SkepticismPositive· 100

Learn More →